You are here Resources
Tuesday, May 21, 2013

  Best Recovery Reads

   
 
2012

Other books by David Healy


Pharmageddon
David Healy (Author)

This searing indictment, David Healy's most comprehensive and forceful argument against the pharmaceuticalization of medicine, tackles problems in health care that are leading to a growing number of deaths and disabilities. Healy, who was the first to draw attention to the now well-publicized suicide-inducing side effects of many anti-depressants, attributes our current state of affairs to three key factors: product rather than process patents on drugs, the classification of certain drugs as prescription-only, and industry-controlled drug trials. These developments have tied the survival of pharmaceutical companies to the development of blockbuster drugs, so that they must overhype benefits and deny real hazards. Healy further explains why these trends have basically ended the possibility of universal health care in the United States and elsewhere around the world. 



 
2012

Other books by Peter Breggin
Psychiatric Drug Withdrawal: A Guide for Prescribers, Therapists, Patients and their Families
Peter R. Breggin MD (Author)

This is the first book to establish guidelines and to assist prescribers and therapists in withdrawing their patients from psychiatric drugs, including those patients with long-term exposure to antipsychotic drugs, benzodiazepines, stimulants, antidepressants, and mood stabilizers. It describes a method developed by the author throughout years of clinical experience, consultations with experienced colleagues, and scientific research. Based on a person-centered collaborative approach, with patients as partners, this method builds on a cooperative and empathic team effort involving prescribers, therapists, patients, and their families or support network. 
            
 
2012
The Essential Guide to Psychiatric Rehabilitation Practice
William A. Anthony & Marianne Farkas (Authors)

The purpose of this Guide is to describe the complexities of the psychiatric rehabilitation process, programs, and principles in a most straightforward and user-friendly way, in order to improve the implementation, practice, and study of psychiatric rehabilitation.

Features of the Guide include checklists, examples, forms, and key principles that support effective implementation. Regardless of the program model, setting, or discipline; the psychiatric rehabilitation process effectively helps people living with psychiatric disabilities become more successful and satisfied in living, learning, working, and social environments of their choice.

Preview Book  

 
 
2011
Rethinking Psychiatric Drugs: A Guide for Informed Consent
MD Grace E. Jackson (Author)

Dr. Grace Jackson is a board certified psychiatrist who graduated summa cum laude from California Lutheran University with a Bachelor of Arts in Political Science and a Bachelor of Science in Biology, as well as a Masters Degree in Public Administration. She earned her Medical Degree from the University of Colorado Health Sciences Center in 1996 and completed her internship and residency while in the U. S. Navy. Following her service as a staff psychiatrist at Bethesda Naval Hospital, she worked in the North Carolina prison system. Dr. Jackson has lectured widely in the United States and Europe, and has testified as an expert witness in forced medication trials. Her interests include philosophy, history, politics, and law.

 
2011




Your Child Does Not Have Bipolar Disorder: How Bad Science and Good Public Relations Created the Diagnosis (Childhood in America)
Stuart L Kaplan M.D. (Author)

Author Stuart L. Kaplan, MD, draws heavily on his forty years of experience as a clinician, researcher, and professor of child psychiatry to make the argument that bipolar disorder in children and adolescents is incorrectly diagnosed and incorrectly treated.

As Dr. Kaplan explains, the dramatic rise in this particular diagnosis is not based on scientific evidence, nor does it reflect any new discovery or insight about the etiology or treatment of the disorder. In fact, the opposite is the case: the scientific evidence against the existence of child bipolar disorder is so strong that it is difficult to imagine how it has gained the endorsement of anyone in the scientific community.


 
2010


 
Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness in America
Robert Whitaker (Author)

Award-winning science and history writer Robert Whitaker investigates a medical mystery: Why has the number of disabled mentally ill in the United States tripled over the past two decades? Every day, 1,100 adults and children are added to the government disability rolls because they have become newly disabled by mental illness, with this epidemic spreading most rapidly among our nation’s children. What is going on?
 
The book challenges readers to think through that question themselves. Readers will be startled—and dismayed—to discover what was reported in the scientific journals.

 
2009
Agnes's Jacket: A Psychologist's Search for the Meanings of Madness
Gail Hornstein (Author)

A vast gulf exists between the way medicine explains psychiatric illness and the experiences of those who suffer. Hornstein’s luminous work helps us bridge that gulf, guiding us through the inner lives of those diagnosed with schizophrenia, bipolar illness, depression, and paranoia and emerging with nothing less than a new model for understanding one another and ourselves.

 
2009
The Myth of the Chemical Cure: A Critique of Psychiatric Drug Treatment 
Joanna Moncrieff (Author)

This controversial book overturns the claim that psychiatric drugs work by correcting chemical imbalance, and analyzes the professional, commercial and political vested interests that have shaped this view. It provides a comprehensive critique of research on drugs including antidepressants, antipsychotics and mood stabilizers.


 
 
2007  
Toward a Vision of Recovery for Mental Health and Psychiatric Rehabilitation Services 
William A. Anthony (Author)

This revised and expanded second edition of Toward a Vision of Recovery traces Dr. William Anthony's thoughts on recovery, beginning with a declaration in 1992 that recovery should be the guiding vision of the entire mental health field.
He follows with a discussion of the standards for developing recovery-oriented service systems, the need to incorporate helping processes that are fundamental to people's recovery into evidence-based mental health practice, and the need to transform research in the field by exploring the barriers and the facilitators to recovery--or simply, researching what makes people well. Anthony and co-authors, Cheryl Gagne and William White, conclude with an analysis of recovery as the common vision of the fields of mental health and addictions.
An extensive list of resources and publications related to recovery from mental illnesses is included at the end of the book.

View excerpts from book
 
 
1981 
Levels of Schizophrenia
Albert E. Scheflen (Author)

Levels of Schizophrenia is a posthumously published work of Albert E. Scheflen, a psychiatrist whose interest in schizophrenia covered both clinical practice and research. He died of cancer at the age of 60 while this book was in production.

His basic idea was to apply general systems theory to schizophrenia and to integrate what he considered to be eight basic levels from the societal to the molecular. The levels are: (1) society, (2) institutions, (3) family, (4) mother-infant dyads, (5) bodystates and emotions, (6) physiological subsystems, (7) neuropsychological organizations, and (8) neural microstructure and its metabolism.

He believed that his schema would at last lead to an integration on several levels of the multi-faceted and often contradictory explanations offered by the puzzling problems of schizophrenia.
 
 

     
           
           

Journal Articles
 
Most Recently Added 

The Myth of Schizophrenia as a Progressive Brain Disease. Robert B. Zipursky, Thomas J. Reilly, Robin M. Murray.Schizophrenia Bulletin, doi:10.1093/schbul/sbs135, Oxford Journals. Published online November 20, 2012
 
Solutions
Addressing non-adherence to antipsychotic medication: a harm-reduction approach. Aldridge, M.A. Journal
       of Psychiatric and Mental Health Nursing,
2011. 
Identifying Priorities for Patient-Centered Outcomes Research for Serious Mental Illness. Agency for
       Healthcare Research and Quality, September 2011, www.ahrq.org
Two-year outcome in first episode psychosis treated according to an integrated model. Is immediate
       neuroleptisation always needed?
 Lehtinen, V. European Psychiatry15 (2000):312-320.
Five-year experience of first-episode nonaffective psychosis in Open-Dialogue approach. Seikkula,
       J. Psychotherapy Research  16 (2006):214-228.
Effects of exercise training on older patients with major depression. Blumenthal, J.  Archives of Internal
       Medicine 
159 (1999):2349-56.
Exercise treatment for major depression. Babyak, M. Psychosomatic Medicine 62 (2000):633-8.

Advancements

Publication Bias in Antipsychotic Trials: An Analysis of Efficacy Comparing the Published Literature to the 
     US Food and Drug Administration Database
.
Erick H. Turner, Daniel Knoepflmacher, Lee Shapley.
     PLoS Medicine March 2012, Vol. 9, Issue 3, e1001189.
Bridging Science to Service: Using the Rehabilitation Research and Training Center Program to ensure that 
     research based knowledge makes a difference
Journal of Rehabilitation Research and Development
     vol 44, 6, 2007, 879-92. 
Happy birthday neuroleptics! 50 years later: la folie du doute. Emmanuel Stip. Eur Psychiatry 2002; 17:1-5. 
Recent advancements in understanding mental illness and psychotic experiences.
 The British
     Psychological Society
, June 2000. www.bps.org.uk
Maintenance Antypsychotic Therapy: Is the Cure Worse than the Disease? Gardos, G., Cole, J. American
     Journal of Psychiatry
 133:1, January 1976.

Bipolar
Age effects on antidepressant-induced manic conversion. Martin, A. Archives of Pediatric Adolescent
     Medicine 158 (2004):773-80.
Risk for bipolar illness in patients initially hospitalized for unipolar depression. Goldberg, J. American
     Journal of Psychiatry 
158 (2001):1265-70.
Rapid cyclers, temperament, and antidepressants. Kukopulos, A. Comprehensive Psychiatry 24
     (1983):249-58.
Diagnosing bipolar disorder and the effect of antidepressants. Ghaemi, N. Journal of Clinical Psychiatry 61
     (2000):804-9.
Antidepressants in bipolar disorder. Ghaemi, N. Bipolar Disorders 5
     (2003):421-33.
Use of antidepressants to treat depression in bipolar disorder. El-Mallakh, R. Psychiatric Services  53
     (2002):580-4.
Duration and stability of the rapid-cycling course. Koukopoulos, A. Journal of Affective Disorders 72
     (2003):75-85.
Antidepressant-associated chronic irritable dysphoria (acid) in bipolar disorder. El-Mallakh, R. Journal of
     Affective Disorders 
84 (2005):267-72.
The prospective course of rapid-cycling bipolar disorder. Schneck, C. American Journal of Psychiatry 165
     (2008):370-77.
The long-term natural history of the weekly symptomatic status of bipolar I disorder. Judd, L. Archives of
     General Psychiatry 
59 (2002):530-7.
A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II
     disorder
.
 Judd, L. Archives of General Psychiatry 60 (2003):261-9.
12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Keck,
     P. American Journal of Psychiatry 155 (1998):646-52.
Demographic and clinical characteristics of individuals in a bipolar disorder case registry. Kupfer, D. Journal of
     Clinical Psychiatry 
63 (2002):120-5.
Outpatients with schizophrenia and bipolar I disorder. Dickerson, F. Psychiatry Research 102 (2001):21-27.
Functional impairment and cognition in bipolar disorder. Zarate, C. Pyschiatric Quarterly 71 (2000):309-29.
Disability and its treatment in bipolar disorders. Huxley, N. Bipolar Disorders 9 (2007):183-96.
The increasing medical burden in bipolar disorder. Kupfer, D. JAMA 293293 (2005): 2528-30.
 


Depression
Do antidepressants and antianxiety drugs increase chronicity in affective disorders? Fava,
     G. Psychotherapy and Psychosomatics 61 (1994):125-31.
Can long-term treatment with antidepressant drugs worsen the course of depression? Fava, G. Journal of
     Clinical Psychiatry 
64 (2003):123-33.
Holding on, depression, sensitization by antidepressant drugs, and the prodigal experts. Fava,
     G. Psychotherapy and Psychosomatics 64 (1995):57-61.
Potential sensitising effects of antidepressant drugs on depression. Fava, G. CNS Drugs 12 (1999):247-56.
One-year clinical outcomes of depressed public sector outpatients. Rush, J. Biological Psychiatry 56
     (2004):46-53.
Outcome of anxiety and depressive disorders in primary care. Ronalds, C. British Journal of Psychiatry 171
     (1997): 427-33.
Treatment of depression related to recurrence. Weel-Baumgarten, E. Journal of Clinical Pharmacy and
     Therapeutics 
25 (2000):61-6.
The impact of antidepressant treatment on population health. Patten, S.  Population Health Metrics 2
     (2004):9-16.
The effects of detection and treatment on the outcome of major depression in primary care. Goldberg,
     D.  British Journal of General Practice 48 (1998): 1840-4.
Pattern of antidepressant use and duration of depression-related absence from work. Dewa, S. British
     Journal of Psychiatry 
183 (2003):507-13.
Characteristics and significance of untreated major depressive disorder. Coryell, W. American Journal of
     Psychiatry
 152 (1995): 1124-9.
The naturalistic course of major depression in the absence of somatic therapy. Posternak, M. Journal of
     Nervous and Mental Diseases 
194 (2006):324-9.
Efficacy and Effectiveness of Antidepressants: Current Status of Research. Pigott, H. Edmund
     et al. Psychotherapy and Psychosomatics (2010)79:267–279.
A long-term view of serious emotional problems: “Is there such a thing as „getting better‟ from this or not?”
     Critical issues along the journey to an answer
. Hess, J. Alpine Academy Research Series, Utah Youth
     Village, 2010
Blue again: perturbational effects of antidepressants suggest monoaminergic homeostasis in major
     depression
.
 Andrews, Paul W. et al. Frontiers in Psychology 2 (2011).





Pediatric Studies and Papers

Children, Adolescents, & Psychiatric Medication. Prepared by Lee Combrinck-Graham, MD; Judith Pentz, MD; Natalie Sadler MD, April 2012.
Quality of Care for Childhood Attention-Deficit/Hyperactivity Disorder in a Managed Care Medicaid Program.
     Zima, B. et al. Journal of the Americam Academy of Child & Adolescent Psychiatry Vol. 49, Number 12 (December 2010): 1225-1237e11.
3-year followup of the NIMH MTA study. Jensen, P. Journal of the American Academy of Child and
     Adolescent Psychiatry 
46 (2007):989-1002.
MTA at 8 years. Molina, B. Journal of the American Academy of Child and Adolescent Psychiatry 48
     (2009):484-500.
Selective serotonin reuptake inhibitors in childhood depression. Whittington, C. The Lancet 363
     (2004):1341-5.
Depressing research. Editorial. The Lancet 363 (2004):1335.
Efficacy and safety of antidepressants for children and adolescents. Jureidini, J. British Medical
     Journal 
 328 (2004):879-83.
Psychotic side effects of stimulants. Cherland, E. Canadian Journal of Psychiatry 44 (1999): 811-3.
Prior stimulant treatment in adolescents with bipolar disorder. DelBello, M. Bipolar Disorders 3 (2001):53-
     57.
Attention-deficit hyperactivity disorder and juvenile mania. Biederman, J.  Journal of the American Academy
     of Child and Adolescent Psychiatry 
35 (1996):997-1008.
Pediatric-onset bipolar disorder. Faeeda, G. Harvard Review of Psychiatry 3 (1995):171-95.
Bipolar disorder at prospective follow-up of adults who had prepubertal major depressive disorder. Geller,
     B. American Journal of Psychiatry 158 (2001):125-7.
Antidepressant exposure in bipolar children. Cicero, D. Psychiatry 66 (2003):317-22.
Pediatric bipolar disorder. Faedda, G. Bipolar Disorders 6 (2004):305-13.
Course and outcome of bipolar spectrum disorder in children and adolescents. Birmaher, B. Development
     and Psychopathology 
18 (2006):1023-35.
Raine ADHD Study: Long-term outcomes associated with stimulant medication in the treatment of ADHD in
     children
.
 Smith, Grant, et al. Government of Western Australia, Department of Health.


Schizophrenia
Dopaminergic Supersensitivity After Neuroleptics.  Muller, P. Psychopharmacology 60 (1978):1-11.   
Neuroleptic-Induced Supersensitivity Psychosis: Chouinard, G. American Journal of Psychiatry 135
     (1978):1409-1410.  
Neuroleptic-Induced Supersensitivity Psychosis: Chouinard, G. American Journal of Psychiatry 137
     (1980):16-20. 
Neuroleptic-induced supersensitivity psychosis, the “hump course,” and tardive dyskinesia. Chouinard,
     G. Journal of Clinical Psychopharmacology 2 (1982):143-4.
The Vermont Longitudinal Study of Persons with Severe Mental Illness, II. Harding, C. American Journal of
     Psychiatry 
144 (1987): 727-734.
Empirical Correction of Seven Myths About Schizophrenia with Implications for Treatment. Harding, C.
     ACTA Psychiatrica Scandanavica 90, suppl. 384 (1990): 140-146.
Factors Involved in Outcome and Recovery in Schizophrenia Patients Not on Antipsychotic
     Medications.
 Harrow, M. Journal of Nervous and Mental Disease 195 (2007): 407-414.
Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of bene!ts, risks, neurobiology and ethics in the era of early intervention. S.M. Francey, B. Nelson, A. Thompson, A.G. Parker, M. Kerr, C. Macneil, R. Fraser, F. Hughes, K. Crisp, S. Harrigan, S.J.Woodd, M. Berka, P.D. McGorry. Schizophrenia Research 119 (2010) 1-10. www.elsevier.com/locate/schres
Cognitive therapy for people with a schizophrenia spectrum diagnosis not taking antipsychotic medication:
     an exploratory trial
. A. P. Morrison, P. Hutton, M. Wardle, H. Spencer, S. Barratt,
     A. Brabban, P. Callcott, T. Christodoulides, R. Dudley, P. French, V. Lumley, S. J. Tai
     and D. Turkington. Psychological Medicine, pp1-8. Cambridge University Press, 2011. 
     doi:10.1017/S0033291711001899.
Randomized Trial to Evaluate the Efficacy of Cognitive Therapy for Low-Functioning Patients With
     Schizophrenia
. Paul M. Grant, PhD; Gloria A. Huh, 
MSEd; Dimitri Perivoliotis, PhD; Neal M. Stolar, MD,
     PhD; Aaron T. Beck, MD. Arch Gen Psychiatry. Published online October 3,
     2011. doi:10.1001/archgenpsychiatry.2011.129

Andreasen Drops a Bombshell: Antipsychotics Shrink the BrainMad in America Blog
Updates on the EpidemicMad in America Blog
The Myth of Schizophrenia as a Progressive Brain Disease. Robert B. Zipursky, Thomas J. Reilly, Robin M. Murray. Schizophrenia Bulletin, doi:10.1093/schbul/sbs135, Oxford Journals. Published online November 20, 2012. 



 

   
Recovery: Life Stories
 
 
  I Got Better
A Foundation-supported effort to chronicle the stories of people around the world who have experienced and overcome mental health challenges. Video and written testaments to the uniqueness and creativity of every road to recovery.


 
 
National Empowerment Center
NEC is the national leader in supporting the organizational development of "consumer-run", recovery-oriented mental health services.
 
 

First Person Narratives of Madness
Author & professor Gail Hornstein shares this bibliography of first person accounts collected from her decades of research.
       
   
           
           

FEMHC is a U.S. 501(c)(3) non-profit organization Privacy StatementTerms Of Use Xhtml 1.0 CSS 2.0